Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001699737-25-000022
Filing Date
2025-11-19
Accepted
2025-11-19 20:52:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 18539
2 JOINT FILING AGREEMENT ex-99-11202025_011153.htm EX-99.1 4182
  Complete submission text file 0001699737-25-000022.txt   24325
Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 (650) 285-4270
Samsara BioCapital, L.P. (Filed by) CIK: 0001699737 (see all company filings)

EIN.: 813958301 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 50 RUE DE DIJON DAIX I0 21121
Business Address 50 RUE DE DIJON DAIX I0 21121 33380447500
Inventiva S.A. (Subject) CIK: 0001756594 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91576 | Film No.: 251500791
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)